Covered recipient · General Payments record
AUDREEN LOUIS SINGSON
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2019–2024
$2,797.23
- Reported across 206 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $306.15 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $91.85 | 5 |
| Acerta Pharma LLC | $62.10 | 3 |
| Novo Nordisk AS | $45.11 | 2 |
| Corcept Therapeutics | $20.75 | 1 |
| Lilly USA, LLC | $18.64 | 1 |
| Exact Sciences Corporation | $17.98 | 1 |
| PFIZER INC. | $17.56 | 1 |
| Antares Pharma, Inc. | $16.92 | 1 |
| Amgen Inc. | $15.24 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.99 | 02/08/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1106113959 | CMS |
| ABBVIE INC. | $25.60 | 03/12/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1106113961 | CMS |
| ABBVIE INC. | $18.98 | 03/28/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1106113963 | CMS |
| ABBVIE INC. | $15.48 | 05/28/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1106113965 | CMS |
| ABBVIE INC. | $14.80 | 10/08/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1106113967 | CMS |
| Amgen Inc. | $15.24 | 01/09/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1117384463 | CMS |
| Antares Pharma, Inc. | $16.92 | 10/15/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1146486110 | CMS |
| AstraZeneca Pharmaceuticals LP | $33.41 | 07/31/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1104298604 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.87 | 08/13/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1105256778 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.82 | 09/30/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1105522965 | CMS |
| Corcept Therapeutics | $20.75 | 09/17/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1117748415 | CMS |
| Exact Sciences Corporation | $17.98 | 09/26/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1114508241 | CMS |
| Lilly USA, LLC | $18.64 | 08/29/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1136002067 | CMS |
| Novo Nordisk Inc | $22.74 | 01/11/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1097425878 | CMS |
| Novo Nordisk Inc | $22.37 | 10/21/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1097298109 | CMS |
| PFIZER INC. | $17.56 | 08/01/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1131852667 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.